Activation of NAD(P)H Oxidase by Tryptophan-Derived 3-Hydroxykynurenine Accelerates Endothelial Apoptosis and Dysfunction In Vivo

• Published in: Circulation research Vol. 114; no. 3; pp. 480 - 492
• Main Authors: Wang, Qiongxin, Zhang, Miao, Ding, Ye, Wang, Qilong, Zhang, Wencheng, Song, Ping, Zou, Ming-Hui
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 31-01-2014
• Subjects: Animals; Apoptosis - genetics; Cells, Cultured; Endothelium, Vascular - cytology; Endothelium, Vascular - enzymology; Endothelium, Vascular - pathology; Enzyme Activation - physiology; Humans; Kynurenine - administration & dosage; Kynurenine - analogs & derivatives; Kynurenine - physiology; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases - metabolism; Tryptophan - metabolism; Tryptophan - physiology; Up-Regulation - genetics; 3-hydroxykynurenine; apoptosis; indoleamine-pyrrole 2,3,-dioxygenase; kynurenine; NAD(P)H oxidase; oxidative stress; tryptophan
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/CIRCRESAHA.114.302113

RATIONALE:The kynurenine (Kyn) pathway is the major route for tryptophan (Trp) metabolism in mammals. The Trp–Kyn pathway is reported to regulate several fundamental biological processes, including cell death.
OBJECTIVE:The aim of this study was to elucidate the contributions and molecular mechanism of Trp–Kyn pathway to endothelial cell death.
METHODS AND RESULTS:Endogenous reactive oxygen species, endothelial cell apoptosis, and endothelium-dependent and endothelium-independent vasorelaxation were measured in aortas of wild-type mice or mice deficient for nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase subunits (p47 or gp91) or indoleamine-pyrrole 2,3-dioxygenase 1 with or without angiotensin (Ang) II infusion. As expected, AngII increased plasma levels of Kyn- and 3-hydroxykynurenine–modified proteins in endothelial cells in vivo. Consistent with this, AngII markedly increased the expression of indoleamine-pyrrole 2,3-dioxygenase in parallel with increased expression of interferon-γ. Furthermore, in wild-type mice, AngII significantly increased oxidative stress, endothelial cell apoptosis, and endothelial dysfunction. These effects of AngII infusion were significantly suppressed in mice deficient for p47, gp91, or indoleamine-pyrrole 2,3-dioxygenase 1, suggesting that AngII-induced enhancement of Kynurenines via NAD(P)H oxidase–derived oxidants causes endothelial cell apoptosis and dysfunction in vivo. Furthermore, interferon-γ neutralization eliminates AngII-increased superoxide products and endothelial apoptosis by inhibiting AngII-induced Kynurenines generation, suggesting that AngII-activated Kyn pathway is interferon-γ–dependent. Mechanistically, we found that AngII-enhanced 3-hydroxykynurenine promoted the generation of NAD(P)H oxidase–mediated superoxide anions by increasing the translocation and membrane assembly of NAD(P)H oxidase subunits in endothelial cells, resulting in accelerated apoptosis and consequent endothelial dysfunction.
CONCLUSIONS:Kyn pathway activation accelerates apoptosis and dysfunction of the endothelium by upregulating NAD(P)H-derived superoxide.